1-4 of 4
Suiyang Liu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

IDH1 Splicing Alterations in Patients with AML and Their Relationship to Blood 2HG Levels

Sophia Adamia, PhD, Patricia Toniolo, PhDcandidate, Amir T. Fathi, MD, Ilene Galinsky, ANP, Suiyang Liu, Katharine Yen, Hyeryun Kim Kim, Dongwei Zhu, Straley Kim, Martha Wadleigh, MD, David P. Steensma, MD, Ibiayi Dagogo-Jack, MD, Daniel J. DeAngelo, MD PhD, James D. Griffin, MD, Richard M. Stone, MD
Journal: Blood
Blood (2014) 124 (21): 1060.
https://doi.org/10.1182/blood.V124.21.1060.1060
Published: 2014
Journal Articles

OncoHist ® , an rh Histone 1.3, Is Cytotoxic to Acute Myeloid Leukemia Cells and Results in Altered Downstream Signaling

Suiyang Liu, Surender Kharbanda, PhD, Richard M. Stone, MD
Journal: Blood
Blood (2014) 124 (21): 3604.
https://doi.org/10.1182/blood.V124.21.3604.3604
Published: 2014
Journal Articles

MUC1-C oncoprotein promotes FLT3 receptor activation in acute myeloid leukemia cells

Suiyang Liu, Li Yin, Dina Stroopinsky, Hasan Rajabi, Alexandre Puissant, Kimberly Stegmaier, David Avigan, Surender Kharbanda, Donald Kufe, Richard Stone
Journal: Blood
Blood (2014) 123 (5): 734–742.
https://doi.org/10.1182/blood-2013-04-493858
Published: 2014
Includes: Supplemental data
Journal Articles

A Phase I Trial of Escalating Dose of the Rapamycin Analog Everolimus in Combination with the Kinase Inhibitor Midostaurin in Patients (pts) with Relapsed, Refractory or Poor Prognosis Acute Myeloid Leukemia (AML)

Richard M. Stone, MD, Caitlin Driscoll, Ilene Galinsky, ANP, Martha Wadleigh, MD, David P. Steensma, MD, David Avigan, MD, Philip C. Amrein, MD, Suiyang Liu, James D. Griffin, MD, Steven L. McAfee, MD, Eyal C. Attar, MD, Karen K. Ballen, MD, Edward Fox, PhD, Daniel J. DeAngelo, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 3627.
https://doi.org/10.1182/blood.V120.21.3627.3627
Published: 2012